Quantum Biopharma (QNTM) Cash from Discontinued Operations (2019 - 2022)
Quantum Biopharma (QNTM) reported Cash from Discontinued Operations of 504264.0 for Q1 2022, down 175.04% on a YoY basis from 672013.0 in Q1 2021, and up 80.67% sequentially from 2608536.0 in Q4 2021.
Quantum Biopharma (QNTM) Cash from Discontinued Operations (2019 - 2022) Analysis & Trends
Quantum Biopharma (QNTM) has 4 years of Cash from Discontinued Operations data on file, last reported at 504264.0 in Q1 2022.
- For the quarter ending Q1 2022, Cash from Discontinued Operations fell 175.04% year-over-year to 504264.0; the trailing twelve-month figure through Mar 2022 stood at 2558318.0 (down 1670.73% YoY), and the FY2022 full-year result was 1142982.0, up 17.3% from the prior year.
- Cash from Discontinued Operations climbed to 504264.0 in Q1 2022, from 2608536.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 1539547.64 in Q1 2019 to a low of 2608536.0 in Q4 2021.
- A 4-year average of 35838.62 and a median of 141551.32 in 2020 frame the typical range for Cash from Discontinued Operations.
- Across the five-year window, Cash from Discontinued Operations tumbled 194.75% in 2020 and jumped 930.31% in 2021, its largest moves.
- Tracing QNTM's Cash from Discontinued Operations over 4 years: stood at 497509.96 in 2019, then slumped by 91.32% to 43193.64 in 2020, then plunged by 6139.17% to 2608536.0 in 2021, then surged by 80.67% to 504264.0 in 2022.
- Business Quant data shows QNTM's Cash from Discontinued Operations at 504264.0 in Q1 2022, 2608536.0 in Q4 2021, and 314573.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -504,264.00 |
| Mar 31, 2022 | -504,264.00 |
| Dec 31, 2021 | -2.61 Mn |
| Dec 31, 2021 | -2.61 Mn |
| Sep 30, 2021 | 314,573.00 |
| Sep 30, 2021 | 314,573.00 |
| Jun 30, 2021 | 239,909.00 |
| Jun 30, 2021 | 239,909.00 |
| Mar 31, 2021 | 672,013.00 |
| Mar 31, 2021 | 672,013.00 |
| Sep 30, 2020 | 43,193.64 |
| Sep 30, 2020 | 43,193.64 |
| Jun 30, 2020 | -471,396.93 |
| Jun 30, 2020 | -471,396.93 |
| Mar 31, 2020 | -80,935.53 |
| Mar 31, 2020 | -80,935.53 |
| Jun 30, 2019 | 497,509.96 |
| Jun 30, 2019 | 497,509.96 |
| Mar 31, 2019 | 1.54 Mn |
| Mar 31, 2019 | 1.54 Mn |